01 1Qilu Antibiotics Pharmaceutical Co., Ltd.
01 1CEFTAZIDIME FOR INJECTION
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-12-10
Pay. Date : 2013-09-06
DMF Number : 20481
Submission : 2006-12-28
Status : Active
Type : II
20
Qilu Antibiotics Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CEFTAZIDIME FOR INJECTION, with a corresponding US DMF Number 20481.
Remarkably, this DMF maintains an Active status since its submission on December 28, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 10, 2018, and payment made on September 06, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
